Skip to main content
Springer logoLink to Springer
. 2022 Dec 7;55(3):489–501. doi: 10.1007/s11255-022-03434-8

Mechanism of traditional Chinese medicine in treating overactive bladder

Yuxiang Liao 1, Xin Du 1, Yuanbo Fu 1, Lu Liu 1, Jiangyan Wei 1, Qi An 2, Xuanzhi Luo 2, Fan Gao 2, Shuhan Jia 2, Ying Chang 2, Mengxi Guo 2, Huilin Liu 1,
PMCID: PMC9957912  PMID: 36479677

Abstract

Overactive bladder syndrome (OAB) has made increasing progress in mechanism and treatment research. Traditional Chinese medicine (TCM) is a common complementary therapy for OAB, and it has been found to be effective. However, the intervention mechanism of TCM in the treatment of OAB is still unclear. The aim of this review is to consolidate the current knowledge about the mechanism of TCM: acupuncture, moxibustion, herbs in treating OAB, and the animal models of OAB commonly used in TCM. Finally, we put forward the dilemma of TCM treatment of OAB and discussed the insufficiency and future direction of TCM treatment of OAB.

Keywords: Lower urinary tract disease, Overactive Bladder, Traditional Chinese medicine, Therapy, Mechanism

Introduction

Overactive bladder syndrome (OAB) is defined as a complex of symptoms including urgency, frequency of urination, with or without urinary incontinence [1]. Urgency is the key symptom of OAB, defined as a sudden, intense urge to urinate that is difficult to postpone [2]. Epidemiological studies have shown that [3, 4], these symptoms affect 12–17% of adults in the community. Prevalence increases with age and is similar in men and women [5]. OAB imposes a huge economic burden on the health care system and the whole society. It is estimated that OAB has caused tens of billions of dollars in health budgets and broader economic losses in developed countries [6]. In addition to bringing an economic burden to the medical system, OAB will also cause serious damage to the quality of life of these patients [7]. The etiology of OAB is unknown, but it is known that various neurological and anatomical abnormalities of the lower urinary tract [8] as well as genetics, age, obesity, smoking, caffeine, etc., can cause or exacerbate OAB [9].

Current treatment options include behavioral interventions, medications (e.g., anticholinergic drugs, β-3 adrenergic receptor agonists), electrical nerve stimulation, and botulinum toxin A injections [10]. Anticholinergic and β-3 agonist therapy are the standard first-line pharmacological treatments for treating patients with OAB, but both have many corresponding side effects. For example, anticholinergic side effects include dry mouth, blurred vision, and constipation; β-3 agonist, while having a lower incidence of anticholinergic side effects, exhibit a higher risk of hypertension [11]. Therefore, it is urgent to find a convenient, more effective and less side effect treatment. However, TCM treatments such as acupuncture, herbal medicine and massage have been used in clinical practice for more than 2000 years and are considered as alternative therapies to treat various diseases [12], including treatment of symptoms such as frequent urination, urgency and incontinence in patients with OAB [13, 14]. The mechanism of TCM treatment of OAB is complex and the exact mechanism of different types of TCM treatment remains to be fully elucidated. In recent years, traditional Chinese medicine has achieved some success in the treatment of OAB. This paper reviews the clinical and mechanism of TCM treatment of OAB, hoping to bring new thinking for the treatment and research of OAB.

Animal studies

At present, the understanding of OAB pathogenesis is still limited. Legal, ethical and moral constraints make it difficult to use human tissue for scientific research, and existing treatment guidelines are limited to alleviating symptoms. The application of the animal model in basic research is ethical and plays an important role in the connection between basic experiment and clinic [15]. Although there is no ideal animal model that can fully simulate OAB, we can use animal models of detrusor overactivity (DO) or bladder overactivity to further our understanding of the pathophysiology of OAB and to search for potential treatment options [16]. There are many kinds of OAB animal models, different modeling methods, different characteristics of models, different clinical diseases of OAB, and different application scope of models. These animal models can be categorized into two major types [15]: induced and transgenic/genetic models. Induced models can be further divided into the following categories: peripheral model, central model, induced hypersensitivity/inflammation model and bladder outlet obstruction (BOO) model. The peripheral model presented bladder dysfunction caused by direct impairment of peripheral bladder innerve, blood supply or metabolic state [17], such as OAB caused by feeding a high-fat diet in the hyperlipidemia model. Central models, on the other hand, present damage to the spinal cord, brainstem, or higher nerve centers, with rat T10 spinal cord transection being the most commonly used OAB modeling method for central nervous system injury [18], which can simulate bladder overactivity after human spinal cord injury and is also applicable to bladder C-fibers, bladder smooth muscle, and associated nerves. Hypersensitivity/inflammation models are induced by surgical or short infusion of chemically hazardous substances such as acetic acid, citric acid, capsaicin, cyclophosphamide (CYP) and alpha-bungarotoxin to induce hyper-sensitization of nociceptive afferent fibers in the bladder, which leads to bladder overactivity [19]. BOO model simulates bladder outlet obstruction in patients with an enlarged prostate by partially or completely ligating the urinary tract or bladder neck of rats [19]. It is also a reliable model for the study of lower urinary tract symptoms with etiological validity. Partial urinary tract obstruction in animals leads to some morphological and functional changes in the bladder and neural pathways similar to those pathological changes in humans [15]. Genetic and transgenic models, such as neuronal nitric oxide synthase and prostaglandin receptor knockout mouse models, are an advanced way to study the characteristics of urinary dysfunction [20]. In Table 1, we summarized the reports on the animal studies in OAB with TCM.

Table 1.

A summary of relevant animal studies is presented

Animal models Animals Method Intervention Mechanism Time Journal Author
Central model Female SD rats Spinal cord injury Moxibustion Inhibiting the M2/ATP/P2X3 pathway 2022 Brain Res Wang et al.
Central model Female SD rats Spinal cord injury Acupuncture Inhibiting of TRPV1 channels 2021 Journal of Practical Med Ning et al.
Central model Female SD rats Spinal cord injury Acupuncture Upregulating NGF and NT-3 expression in spinal cord tissue 2021 Chin J of Rehabilitation Theory and Practice Ming et al.
Central model Female SD rats Spinal cord injury Acupuncture Inhibiting the expression of HCN channel 2020 Ann Palliat Med Lu et al.
Central model Aging SD female rats Natural aging Herbs Increasing the sensitivity and expression of β3-AR 2017 Exp Ther Med Xu et al.
Central model Female SD rats Spinal cord injury Acupuncture Inhibiting the apoptosis in spinal cord 2017 Chin J of Rehabilitation Theory and Practice Xu et al.
Central model Male SD rats Fill in the brainstem within 0.5-M sodium acetate Acupuncture Changing the firing properties of bladder activity-related neurons in and around Barrington's nucleus 2012 Neuroscience Research Wang et al.
Peripheral model male C57BL/6 J mice high-fat diet herbs Inhibition of purinergic neurotransmitter transmission 2019 Front pharmacol Wang et al.
Hypersensitivity/inflammation model Male Balb/c mice Cisplatin-induced neurotoxicity Acupuncture Activating PACAP pathway to promote K+ channels 2021 Front Immunol Li et al.
Hypersensitivity/inflammation model Female SD rats Intraperitoneal injection of CYP Acupuncture Inhibiting the ATP/P2X3 pathway 2020 Evid-based compl alt Feng et al.
Hypersensitivity/inflammation model Female Wistar rats Intraperitoneal injection of CYP Herbs Inhibiting P2X3 receptor overexpression 2016 J ethnopharmacol Lee et al.
Hypersensitivity/inflammation model Female SD rats 0.1% acetic acid solution Herbs Inhibiting sensory transmission in C-fiber afferent pathways 2007 J Urol Nishijima et al.
BOO model Male SD rats Oestrodial/testosterone-induced Herbs Inhibiting Ca2+ and ROCK signaling 2021 J ethnopharmacol Miao et al.
BOO model Female SD rats Bladder neck ligation Herbs Enhancement of NO and its transduction pathway 2019 BMC complem altern m Bae et al.
BOO model male Wistar rats Bladder neck ligation Herbs Promoting potassium channel expression 2017 Evid-based compl alt Sun et al.
BOO model Female SD rats Bladder neck ligation Herbs Decreasing the expression of TRPV1 2015 BMC complem altern m Lai et al.
BOO model Female Wistar rats Bladder neck ligation Acupuncture Regulating the excitability of bladder interstitial cells of Cajal 2013 Evid-based compl alt Feng et al.
BOO model Female SD rats Bladder neck ligation Herbs Blocking L-type Ca2+ channel and activating BKCa channel 2013 Eur Rev Med Pharmacol Sci Jiang et al.

Because of the complex pathogenesis of OAB and the subjective feeling of "urgency", there is no single model that can explain the complete mechanism of OAB in humans. The future development of OAB models should also take into account the complexity of the mechanism itself, fully include the advantages of the current models and reduce each other's shortcomings, so as to establish a more comprehensive model covering the multiple pathogeneses of OAB, to provide new references for future OAB mechanism research and interventions.

Mechanisms of TCM in OAB

Acupuncture, moxibustion, herbal medicine, and massage, as classical TCM treatments, are regarded as an economical and safe alternative, and an increasing number of OAB patients may be willing to seek this treatment option with fewer side effects or less risks. There are several clinical trials by scholars in the United States, the United Kingdom and China, demonstrating the effectiveness and low side effects of acupuncture in the treatment of OAB [2125]. Moxibustion is also a well-known non-invasive therapy that directly or indirectly stimulates acupoints through moxa to promote the recovery of many diseases, especially in chronic and refractory diseases [26]. Although not widely used in Western countries, moxibustion is a common method for symptom relief in Eastern regions such as China, Japan and Korea [27], and is easy for many OAB rehabilitation patients to perform on their own at home due to its efficacy, simplicity, and ease of use. This has recently attracted more attention from researchers [28]. Herbal therapy is based on syndrome differentiation to meet the individual needs of patients [29]. In recent years, a great deal of progress has been made in herbal medicine treatment of OAB, and some promising ingredients and TCM formulations have been found that can delay the progression of OAB, reduce the frequency and urgency of urination, and improve the recovery of bladder function [30]. Massage is also a simple, economical, safe and self-sufficient treatment and is one of the most popular treatments in complementary and alternative medicine for stress reduction, pain relief and other conditions [31]. It has been reported to be effective in alleviating the symptoms of OAB [32], even if massage is not as much evidence as acupuncture, herbal medicine, and recent exploration has yielded some evidence. In this article, the mechanism of TCM treatment of OAB is reviewed as follows:

Improvement of bladder detrusor function

Effects of TCM on neurotransmitter pathways in OAB

The balance between the discharge and storage functions of the bladder requires a complex interplay of multiple neurotransmitters between the autonomic nerves (regulated by the sympathetic and parasympathetic nerves) and the somatic nerves (regulated by the pudendal nerves) [8]. Neurotransmitter signaling pathways mainly include cholinergic signaling pathways, purinergic signaling pathways, β adrenergic signaling pathways and adrenergic signaling pathways.

Inhibition of cholinergic signaling pathways in OAB In the cholinergic pathway [3335], acetylcholine is a contractile neurotransmitter released by the sacral medullary parasympathetic post-ganglia fibers, which promotes detrusor contraction by mediating M receptor. M-Acetylcholine receptors can be divided into 5 subtypes, M1–M5. M2 and M3 receptors play an important role in detrusor contractile activity. M3 receptor plays a direct contractile role, while M2 receptor plays an indirect mediating role [36, 37]. Based on the cholinergic pathway, one study designed controlled experiments with M receptor agonists and M2 receptor blockers, and moxibustion significantly inhibited the expression of M2, but not M3, in the bladder detrusor muscle of neurogenic detrusor overactivity (NDO) rats [38]. Furthermore, a large number of experimental studies have also confirmed the regulatory effect of various Chinese herbal extracts on smooth muscle M receptor, which has been reviewed in detail [39].

Inhibition of purinergic signaling pathways in OAB Adenosine triphosphate (ATP) is a signaling molecule that regulates cellular processes and is an important factor in normal urine storage and urination. Bladder dysfunction such as OAB, lower urinary tract symptoms, bladder outlet obstruction and aging are associated with abnormal increase in ATP [4042]. ATP in the bladder mainly comes from the urothelium [41], in the process of a full bladder, urothelium by mechanical force to stimulate the active release of ATP, then through acting on the afferent nerve endings P2X3 receptor activation micturition reflex, at the same time can also be applied to mesenchymal cells and detrusor cells P2X3 receptor on the surface of the cell membrane so as to promote the bladder contraction [43]. CYP-induced OAB rats showed increased ATP release in bladder urothelium, and the number of P2X3 receptor in bladder afferent nerve endings was significantly higher than that in normal rats [44]. Acupuncture can inhibit ATP overexpression and release in bladder epithelial cells of OAB rats and reduce the activation of the P2X3 receptor, thus it could effectively inhibit detrusor overactivity [45]. In the experiment of TCM formula Suo-Quan-Wan intervention in diabetic OAB model mice, the experiment showed that SQW could directly act on the bladder to improve the bladder function, rather than change the hyperglycemic status of mice and the mechanism may be that SQW inhibits ATP vesicle transport by down-regulating the expression levels of myosin Va and SLC17A9 in detrusor muscle [46]. Some researchers used moxibustion to intervene NDO rats, and the results showed that moxibustion could reduce the content of ATP in bladder mucosa, increase the content of NO in bladder mucous membrane, and reduce the expression of P2X3 receptor protein and mRNA in DO rats, thus improving bladder function [38]. In addition, Ba-Wei-Di-Huang-Wan, a Chinese medicine prescription, can improve CYP-induced persistent DO by inhibiting the overexpression of P2X2, P2X3, M2 and M3 receptor proteins in the mucosa, and the overexpression of M2 and M3 receptor proteins in detrusor muscle [47].

Promoting nitrergic signaling pathways in OAB In the urinary system, NO as a non-adrenergic, non-cholinergic inhibitory neurotransmitter is involved in the regulation of lower urinary tract function [48]. NO is synthesized by nitric oxide synthase, and NOS-positive nerve fibers are widely distributed in bladder and urethra tissues. Through the NO-cGMP signaling pathway, NO can effectively relax the lower urinary smooth muscle and reduce urethral pressure during normal urination, which is of great significance for maintaining normal urinary bladder storage and urination functions [49]. It is well established that reduced NO synthesis is closely associated with increased detrusor excitability due to a variety of causes [50]. Multiple studies [51, 52], have shown that electroacupuncture can promote the generation and secretion of nitrogen-energetic neurotransmitters in bladder tissue, thus improving bladder function. The TCM formula Wu-Zi-Yan-Zong-Wan (a mixture of berry extracts) can effectively treat bladder overactivity induced by partial urinary tract obstruction, and the formula shows anti-oxidant, anti-inflammatory, anti-physostigmine, as well as enhancing nitric oxide and its pathway [53]. The TCM formula Sang-Piao-Xiao-San also activates the PI3K/AKT-mediated NO-cGMP-PKG signaling pathway, upregulating NO production and thereby relaxing smooth muscle [54].

Promoting adrenergic signaling pathways in OAB Adrenergic β3 receptor (β3-AR) is the primary subtype of β-AR regulating detrusor relaxation in rats and humans, directly mediating detrusor relaxation [55]. β-AR receptor agonists such as isoproterenol can provoke detrusor diastolic muscle in mammals by enhancing cyclic adenosine monophosphate(cAMP) concentration [56]. This process includes: β-AR activates adenylate cyclase through excitatory G protein, and then catalyses ATP transformation to generate cAMP as a second messenger. As a second messenger, cAMP can activate PKA [57], thus coordinating the phosphorylation of smooth muscle contraction elements and increasing intracellular calcium reuptake and excretion. Stimulation of the calcium ion-activated K+ channel leads to membrane hyperpolarization, and other pathways ultimately lead to smooth muscle relaxation [56, 58, 59]. A study based on this pathway [60], observing the OAB model of natural aging rats, showed that the TCM formula Suo-Quan-Wan could regulate the contraction of the detrusor muscle by increasing the AC activity, cAMP and PKA content, and β3-AR receptor protein mRNA expression in detrusor cells.

In summary, prescriptions composed of the same herbs can show different targets. Acupuncture at the same acupoint can also produce various effects. This may be a multi-target display of TCM. As shown in Fig. 1, acupuncture, moxibustion and herbal medicine affect various neurotransmitter pathways. It is noteworthy that the role of urothelium has attracted increasing attention, emphasizing an afferent "urotheliogenic" hypothesis that urgency begins with urothelium [61]. In short, the possibility of bladder dysfunction was elucidated through the perception of mechanical and chemical abnormalities in the urothelium. These studies provide new ideas for exploring the mechanism of TCM. At present, the research on the mechanism of TCM in treating OAB is mostly analyzed from a single point of view, but the multi-structure and the multi-link relationship has not been analyzed and discussed, which can not fully reflect the two-way regulation and multi-target characteristics of TCM. The neurotransmitter effects of TCM on OAB need further study.

Fig. 1.

Fig. 1

A model illustrating possible intervention mechanism in TCM affects the chemical interactions between urothelium, afferent nerves, efferent nerves, and fibroblasts in the urinary bladder. Acupuncture and moxibustion can promote the synthesis and release of NO, reduce the synthesis and release of ATP, down-regulate the expression of P2X receptor protein, and inhibit the excessive contraction of the detrusor muscle. Herb medicine can participate in the regulation of multiple neurotransmitters, such as Suo-Quan-Wan can inhibit the expression of the M receptor and P2X receptor, and up-regulate the expression of the adrenergic receptor. Wu-Zi-Yan-Zong-wan can enhance the role of nitric oxide and its transduction pathway

Effects of TCM on ion channel pathways in OAB

In addition to the neurotransmitter pathways, the ion channel pathways are one of the main mechanisms that regulate the coordination of contraction and relaxation of bladder smooth muscle cells [62], including voltage-gated calcium channels (Cav) and transient receptor potential (TRP) channels for enhanced excitation of the detrusor muscle, and K+ channels for reduced excitation [63].

Ca2+ channel The dynamic interaction between bladder smooth muscle ion channels determines the overall level of Cav channel activity. The net influx of calcium through the Cav channel increases the intracellular calcium concentration, which triggers bladder smooth muscle contraction [63]. Under pathological conditions, high Ca2+ concentration in detrusor muscle cells is one of the important factors leading to detrusor muscle overactivity [64]. Berberine, derived from herbal Coptis chinensis Franch, improves bladder function by significantly inhibiting intracellular Ca2+ levels and ROCK-mediated contraction of detrusor cells [65]. Similarly, rhynchophylline, derived from the Uncaria plant, can inhibit the contraction of rat bladder strips by blocking L-type calcium channels and activating big-conductance calcium-activated potassium channels [66].

K+ channel Several families of K+ channels expressed and functional in bladder smooth muscle include voltage-gated K+ channels, Ca2+-activated K+ channels, inward-rectifying ATP-sensitive K+ channels, and two-poredomain K channels [67]. In general, the opening of the K+ channel causes hyperpolarization of the cell membrane, limiting the flow of calcium ions through the L-type Cav channel and causing relaxation of the bladder smooth muscle. Conversely, inhibition of K+ channels in detrusor smooth muscle cells leads to membrane depolarization and activation and opening of L-type Cav channels, leading to detrusor smooth muscle contraction [68]. The advantage of K+ channel opening agent in the treatment of OAB is that it can reduce the involuntary contraction during urination storage and the contractile activity caused by external stimulation, without affecting the bladder pressure during urination [69]. There is still a lack of K + channel openers with bladder specificity, and in the future, the use of bladder-specific K+ channel openers may replace current first-line pharmacotherapy [67]. There is increasing evidence that TCM can inhibit the involuntary contraction of the bladder urine storage period without affecting the contraction of the detrusor muscle during the bladder urination period, which is similar to the effect of K+ channel openers [38, 45]. Therefore, we believe that K+ channel may be one of the important targets for TCM treatment of OAB. For example, abnormal expression of potassium channels was found in detrusor muscle in BOO-related OAB model rats. Xian-jia-tang, a Traditional Chinese medicine decoction, could significantly inhibit the expression of Kv2.1 and Kv1.5 in detrusor muscle, but increased the expression of BK, SK2/3 and KATP, suggesting that the effect of Xian-jia-tang on BOO rats was related to the K+ channel in detrusor muscle [70]. In addition, acupuncture could be upregulated, pituitary adenylate cyclase-activating polypeptide [71], and then cAMP-activated PKA, promoting phosphorylation of K+ channel and hyperpolarization of the cell membrane. This indirectly inhibits the activity of L-type voltage-dependent calcium channels on the cell membrane, prevents extracellular Ca2+ from entering muscle cells, reduces intracellular Ca2+ concentration and promotes the relaxation of smooth muscle cells [72].

TRP channel Transient receptor potential channels are non-selective cation channels, including TRPV1, TRPV2, TRPV4, TRPM8, and TRPA1, and act as sensors for stretch and/or chemical stimulation to convey the sensation of bladder dilation [73, 74]. In the urinary system, TRPV1 is the most studied channel [74], which is expressed in primary sensory afferent fibers, urinary tract epithelium and smooth muscle cells and promotes afferent excitation during bladder filling [75]. Desensitization of this channel with TRPV1 agonists is often used clinically to treat OAB, and its clinical use has been reviewed in detail elsewhere [7678]. Animal experimental studies showed that TRPV1 protein expression in the bladder tissue of NDO was significantly higher than that in the sham-operated group, and TRPV1 protein expression levels in the bladder tissue of rats in both the electroacupuncture and inhibitor groups were significantly lower compared with the model group [79]. Suo-Quan-Wan can also promote the recovery of bladder function by regulating TRPV1 expression [80].

HCN channel Hyperpolarization-activated Cyclic Nucleotide-gated channels (HCN) in bladder interstitial cells of Cajal (ICC) are important and special ion channels in bladder ICCs [81]. At the same time, HCN is the structural basis for the generation of overactivated positive ion flow currents, and an increase or decrease in its protein expression directly causes excitability in pacemaker cells, which may have a critical role in the maintenance and regulation of bladder cell excitability [81]. In the neurogenic OAB rat model, the expression of HCN channel in ICCs was significantly up-regulated after spinal cord injury, while electroacupuncture at "Ci-Liao" and "Hui-Yang" acupoints inhibited the expression of HCN channel [82]. In addition, experiments with acupuncture intervention in BOO-related OAB model rats showed [83] that HCN2 mRNA and protein expression was upregulated in the bladder of OAB rats, and acupuncture reversed this rise; ICC results in the bladder of OAB rats cultured in vitro showed higher intracellular Ca2+ concentrations than in normal control rats, and Ca2+ concentrations decreased after acupuncture treatment.

The importance of ion channels in the excitability and contractility of detrusor suggests that defects, alterations, or mutations in ion channels may lead to certain forms of bladder lesions, also known as channelopathies [84]. At present, there have been many reports that TCM can treat OAB through ion channels, but these experiments have not yet described the upstream mechanism of regulating ion channels of TCM in detail, which needs further study.

Improvement of abnormal bladder nerve signals in OAB

Inhibition of C-fiber activity

In recent years, the role of afferent nerve fibers in OAB has been paid more and more attention [85]. The main nerves controlling the bladder are the hypogastric nerve, pudendal nerve and pelvic nerve [86]. Among them, the pelvic nerve is parasympathetic and is the most important nerve involved in bladder function, and most of the afferent fibers from the bladder enter the sacral medullary voiding center through the pelvic nerve [87, 88]. The bladder afferent nerves, which can be classified as myelinated sensory A-delta fibers and unmyelinated sensory C-fibers, respond to mechanical and chemical stimuli and then transmit information to the central nervous system about bladder volume and the chemical environment inside the bladder [89]. C-fibers hyperactivity is one of the key pathological mechanisms of OAB [90]. In OAB, changes in peripheral afferent receptors may result from increased release of neurotrophic factors (such as nerve growth factor) in the spinal cord or bladder, resulting in silenced C-fiber sensitization and increased afferent impulses [91, 92]. Some scholars believe that [93] when the needle tip is close to the anterior branch of the second sacral nerve at the deep point of “Zhong-Liao”, it can stimulate the sacral nerve, thus inhibit the excitement of the afferent nerve of the bladder. This process is similar to the regulation of the sacral nerve [94, 95]. It has also been reported that 5-hydroxytryptamine induces hyperexcitability of the C-fiber afferent pathway, leading to pain or bladder overactivity in the presence of mucosal inflammation [96]. Nishijima found a decrease in plasma 5-hydroxytryptamine levels in hypersensitivity OAB model rats after treatment with the TCM formula Ji-Sheng-Shen-Qi-Wan, suggesting that it can inhibit sensory transmission in the C-fiber afferent pathway and maintain the balance between the sympathetic and parasympathetic nervous systems at a lower level to suppress bladder activity [97].

Inhibition of the release of substance P from the afferent nervous system

Substance P (SP) is a sensory neuropeptide found in the afferent nervous system of mammals and innervates smooth muscles such as the detrusor muscle [98]. Once released from the bladder afferent nerve, SP is involved in the mechanoreceptor-mediated micturition reflex [99]. Studies have shown that bladder biopsies from patients with idiopathic detrusor overactivity show a significant increase in fibers containing SP [100], suggesting that SP is closely associated with the occurrence of OAB. Tsai WH showed [101], that excessive SP stimulation enhances the voiding reflex through activation of neurokinin type 1 receptors and increases the release of reactive oxygen species from intercellular adhesion molecule-1 mediated adhesion and infiltration of inflammatory cells, leading to chronic bladder inflammation and hyperreflexia. The Chinese herbal compound Ba-Wei-Di-Huang-Wan and its active ingredient strychnine may ameliorate OAB by inhibiting SP-induced bladder afferent signaling, intercellular adhesion molecule-1 expression, and reactive oxygen species counts.

Improvement of neuronal activity in the brain in OAB

Advanced voiding centers include the pontine micturition center (PMC) and periaqueductal gray (PAG) [102]. The PAG receives afferents from the lumbosacral medulla and is directly connected to the PMC, which controls voiding via the efferent sacral parasympathetic nucleus [103]. Studies have shown that psychological stress or increased sympathetic activity leads to central sensitization, which in turn leads to OAB [104]. In the pathogenesis of central sensitization, peripheral nerves usually function normally, but the central neuronal function is altered [105]. These highly sensitive central system neurons show reduced thresholds, greater evoked responses, increased receptive field sizes and ongoing stimulus-independent activity [106]. Wang and his colleagues showed [107] that acupuncture at the sacrum alters the firing patterns of PMCs and their surrounding neurons related to bladder activity; further application of a GABA receptor antagonist (bicuculline) can block the inhibition of bladder activity, suggesting that acupuncture can reduce DO by modulating the GABA receptor system mediating, and thus regulating, the firing of PAG and PMC neurons.

Improvement of the spinal urinary center function in OAB

The spinal cord plays an important role in bladder afferent and efferent signal transduction. The sensory signals during the bladder filling travel upward through the afferent nerves to the dorsal root ganglion of the spinal cord in the lumbosacral segment, where the posterior horn of the spinal cord integrates the sensory information and sends it to the higher voiding center. Therefore, the structure and function of the spinal cord is important in regulating the maintenance of normal bladder voiding [89]. After the injury above the sacral spinal cord, the inhibitory and excitatory controls from the high micturition center on the sacral micturition center are lost, and a new C-fiber-dependent reflex arc is formed in the sacral spinal cord, thus causing bladder overactivity [108]. A Studies showed that electroacupuncture significantly inhibited the expression of apoptotic protein Caspase-3 in the spinal cord tissues of rats; further studies showed that electroacupuncture significantly inhibited cytochrome C and apoptotic protease-activating factor-1 and activated Caspase-9 protein, reduced the rate of spinal cord apoptosis, alleviated secondary spinal cord apoptosis, promoted spinal cord functional remodeling, alleviated secondary spinal cord injury, and regulated innervation of the bladder and pelvic floor [109]. In recent years, it has been proposed that the mechanism of OAB action after spinal cord injury treated with TCM may involve neuro-endocrine network regulation in addition to inhibition of spinal cord cell apoptosis [110]. For example, several studies have shown that acupuncture can increase the protein and mRNA content of endogenous nerve growth factor, neurotrophin 3, and tyrosine kinase receptor A in the spinal cord tissue of DO rats after supra-sacral spinal cord injury, promote the repair of injured nerves and recovery of nerve function and improve bladder storage capacity [111113]. In addition, it should be noted that the whole bladder is rich in nerve growth factors (NGF) that maintain nerve growth and function in the bladder and inhibit apoptosis of nerve cells, which makes the bladder more sensitive. In the DO rat model of spinal cord injury, NGF was expressed in the epithelial and detrusor muscles of the bladder in both groups, and the expression of NGF was significantly higher in the bladder of the model group [114]. Increased NGF expression in the bladder can induce bladder overactivity [115]. Several meta-analyses have also shown a strong relationship between urinary NGF levels and both the diagnosis and treatment of OAB [116]. Therefore, NGF, a nerve growth factor in urine, may serve as a potential biological marker for the diagnostic treatment of OAB [117]. As science advances, we believe that in the future, NGF as a conveniently detectable biomarker can provide reliable evidence for the clinical treatment of OAB after spinal cord injury in TCM.

Dilemma in the research of TCM in OAB

In recent years, TCM treatment of OAB has made some progress, but still faces many difficulties, as shown in Fig. 2. First, the selection of animal models. There are many kinds of OAB animal models, and the application scope of OAB models is also different, which has been reviewed previously. Therefore, how to choose a more suitable model for TCM research needs further exploration, and the current research is mostly from a single angle of analysis, there is no multi-structure, multi-link relationship series analysis. Second, the test of the model—urodynamic detection. Animal models for OAB pathophysiological studies have been successfully established in several species. However, OAB is a clinical diagnosis, and a subconscious sense of urgency is the key to the diagnosis. Different from the urodynamic diagnosis of DO. There is an overlap between urodynamically defined DO and subjectively reported OAB. Not all patients with OAB have DO and DO patients DO not always have a sense of urgency [118]. Therefore, it is technically impossible to establish a specific animal model of OAB. Although the symptoms of urgent urine in animals cannot be quantified, we can substitute them by objective observation of the measurement of bladder pressure in DO. This is why most OAB experimental models are built on DO, and urine flow mechanics is the gold standard to judge the success of model construction. There are two commonly used methods for bladder measurement in animals: manometry in an awake state and manometry in anaesthetic state. Awake bladder manometry is the most widely used method of bladder manometry at present. This method is operated on animals with cystostomy, and bladder manometry is carried out in their awake state. This manometry method is not affected by narcotic drugs and is most consistent with the physiological conditions of rats [119]. However, after cystostomy, there is certain damage to the bladder, which will also affect bladder function [120]. More difficult, we usually conduct a urodynamic test first to confirm the successful establishment of the model, and then start intervention. After cystostomy, moxibustion and acupuncture are difficult to implement. Although bladder manometry under anesthesia is highly controlled and non-invasive to the bladder, the influence of anesthetics on bladder function cannot be ruled out, which may have an impact on the evaluation of the efficacy of an overactive bladder. Therefore, how to eliminate the effect of anesthetics on bladder function and increase the controllability of awake manometry in rats may be an urgent problem to be solved. Third, the accurate location of acupoints plays an important role in acupuncture and moxibustion clinic. However, due to the differences in individual patients and doctors' experience, the location of acupoints in clinical treatment has certain subjectivity and inaccuracy, which affects the curative effect of treatment to varying degrees. In addition, in animal studies, there is no unified standard for animal acupoint location, and there is a big difference between animal acupoint location and human acupoint location. Fourth, at present, there are few large-scale clinical trials to prove the effectiveness of TCM. As mentioned above, the therapeutic effect of acupuncture is closely related to the experience of the physician. To achieve the best results, doctors will adjust the composition of drugs or the collocation of acupoints during the follow-up in real time, which often leads to different prescriptions for each person [121]. Patient acceptance of TCM is lower than that of modern medicine, which makes it difficult to recruit treatment-naive patients. Therefore, these realities present difficulties in the design and operation of clinical or basic trials, and further research is needed to understand the long-term efficacy and mechanism of action of this intervention.

Fig. 2.

Fig. 2

Dilemma in the research of TCM in OAB

Conclusions

In this article, we have summarized the mechanism of Traditional Chinese Medicine in treating with OAB, and summarized the current OAB animal models in TCM treatment. According to the pathogenesis of OAB, we infer that the mechanism of TCM in treating OAB may be to improve the release of abnormal neurotransmitters in urinary tract epithelial cells and the incoming signal of the bladder based on "urotheliogenic" hypothesis. Finally, we point out the development dilemma and prospect of Chinese medicine in OAB. These studies provide a theoretical basis for the clinical treatment of OAB with TCM. TCM may become an effective treatment alternative, with simple operation, low cost and few side effects, although it needs further well-designed research to determine the optimal regimen.

Acknowledgements

The authors are grateful to Dr. Huilin Liu for critically reading the manuscript.

Author contributions

YL collected most of the review material and wrote the main part of the review. XD, LL and YF collected the rest of the material for review. JW, QA, XL, FG, SJ, YC and MG wrote the rest of the review. YL created the chart. HL proposed and reviewed the content of the review article. All authors contributed to this article and approved the submitted version.

Funding

This work was supported by grants from the National Natural Science Foundation of China (no. 81973925).

Data availability

The datasets generated during or analysed during the current study are available from the corresponding author on reasonable request.

Declarations

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Abrams P, Andersson KE, Birder L, Brubaker L, Cardozo L, Chapple C, et al. Fourth international consultation on incontinence recommendations of the international scientific committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn. 2010;29(1):213–240. doi: 10.1002/nau.20870. [DOI] [PubMed] [Google Scholar]
  • 2.Henderson E, Drake M. Overactive bladder. Maturitas. 2010;66(3):257–262. doi: 10.1016/j.maturitas.2010.03.010. [DOI] [PubMed] [Google Scholar]
  • 3.Irwin DE, Kopp ZS, Agatep B, Milsom I, Abrams P. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. Bju Int. 2011;108(7):1132–1138. doi: 10.1111/j.1464-410X.2010.09993.x. [DOI] [PubMed] [Google Scholar]
  • 4.Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, et al. Prevalence and burden of overactive bladder in the united states. World J Urol. 2003;20(6):327–336. doi: 10.1007/s00345-002-0301-4. [DOI] [PubMed] [Google Scholar]
  • 5.Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the epic study. Eur Urol. 2006;50(6):1306–1314. doi: 10.1016/j.eururo.2006.09.019. [DOI] [PubMed] [Google Scholar]
  • 6.Durden E, Walker D, Gray S, Fowler R, Juneau P, Gooch K. The economic burden of overactive bladder (oab) and its effects on the costs associated with other chronic, age-related comorbidities in the united states. Neurourol Urodyn. 2018;37(5):1641–1649. doi: 10.1002/nau.23513. [DOI] [PubMed] [Google Scholar]
  • 7.Chiaffarino F, Parazzini F, Lavezzari M, Giambanco V. Impact of urinary incontinence and overactive bladder on quality of life. Eur Urol. 2003;43(5):535–538. doi: 10.1016/s0302-2838(03)00097-6. [DOI] [PubMed] [Google Scholar]
  • 8.White N, Iglesia CB. Overactive bladder. Obstet Gynecol Clin N Am. 2016;43(1):59–68. doi: 10.1016/j.ogc.2015.10.002. [DOI] [PubMed] [Google Scholar]
  • 9.Dallosso HM, Matthews RJ, Mcgrother CW, Donaldson MM, Shaw C. The association of diet and other lifestyle factors with the onset of overactive bladder: a longitudinal study in men. Public Health Nutr. 2004;7(7):885–891. doi: 10.1079/phn2004627. [DOI] [PubMed] [Google Scholar]
  • 10.Madhuvrata P, Cody JD, Ellis G, Herbison GP, Hay-Smith EJ. Which anticholinergic drug for overactive bladder symptoms in adults. Cochrane Database Syst Rev. 2012;1:D5429. doi: 10.1002/14651858.CD005429.pub2. [DOI] [PubMed] [Google Scholar]
  • 11.De Nunzio C, Nacchia A, Gravina C, Turchi B, Gallo G, Trucchi A, et al. Adverse events related to antimuscarinics and beta-3-agonist: "real-life" data from the eudra-vigilance database. Minerva Urol Nephrol. 2022 doi: 10.23736/S2724-6051.22.04849-2. [DOI] [PubMed] [Google Scholar]
  • 12.Needham J, Lu G. Celestial lancets: a history and rationale of acupuncture and moxa. Cambridge: Cambridge University Press; 1980. [Google Scholar]
  • 13.Liu Z, Liu Y, Xu H, He L, Chen Y, Fu L, et al. Effect of electroacupuncture on urinary leakage among women with stress urinary incontinence: a randomized clinical trial. JAMA. 2017;317(24):2493–2501. doi: 10.1001/jama.2017.7220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Chen LL, Shen YC, Ke CC, Imtiyaz Z, Chen HI, Chang CH, et al. Efficacy of cinnamon patch treatment for alleviating symptoms of overactive bladder: a double-blind, randomized, placebo-controlled trial. Phytomedicine. 2021;80:153380. doi: 10.1016/j.phymed.2020.153380. [DOI] [PubMed] [Google Scholar]
  • 15.Shen JD, Chen SJ, Chen HY, Chiu KY, Chen YH, Chen WC. Review of animal models to study urinary bladder function. Biology (Basel) 2021 doi: 10.3390/biology10121316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Jiang HH, Damaser MS. Animal models of stress urinary incontinence. Handb Exp Pharmacol. 2011;202:45–67. doi: 10.1007/978-3-642-16499-6_3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Shaker H, Mourad MS, Elbialy MH, Elhilali M. Urinary bladder hyperreflexia: a rat animal model. Neurourol Urodyn. 2003;22(7):693–698. doi: 10.1002/nau.10147. [DOI] [PubMed] [Google Scholar]
  • 18.Loutochin O, Al AT, Campeau L, Mahfouz W, Elzayat E, Corcos J. Effect of the anticonvulsant medications pregabalin and lamotrigine on urodynamic parameters in an animal model of neurogenic detrusor overactivity. Neurourol Urodyn. 2012;31(7):1197–1202. doi: 10.1002/nau.21214. [DOI] [PubMed] [Google Scholar]
  • 19.Mcmurray G, Casey JH, Naylor AM. Animal models in urological disease and sexual dysfunction. Br J Pharmacol. 2006;147(Suppl 2):S62–79. doi: 10.1038/sj.bjp.0706630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Burnett AL, Calvin DC, Chamness SL, Liu JX, Nelson RJ, Klein SL, et al. Urinary bladder-urethral sphincter dysfunction in mice with targeted disruption of neuronal nitric oxide synthase models idiopathic voiding disorders in humans. Nat Med. 1997;3(5):571–574. doi: 10.1038/nm0597-571. [DOI] [PubMed] [Google Scholar]
  • 21.Emmons SL, Otto L. Acupuncture for overactive bladder: a randomized controlled trial. Obstet Gynecol. 2005;106(1):138–143. doi: 10.1097/01.AOG.0000163258.57895.ec. [DOI] [PubMed] [Google Scholar]
  • 22.Hargreaves E, Harding C, Clarkson C. Acupuncture in addition to standard conservative treatment for overactive bladder; a feasibility trial for a randomized controlled study. Neurourol Urodyn. 2021;40(7):1770–1779. doi: 10.1002/nau.24741. [DOI] [PubMed] [Google Scholar]
  • 23.Chan YT, Zhang HW, Guo YQ, Chan T, Kwan YK, Lee CK, et al. Effectiveness and safety of acupuncture for elderly overactive bladder population in Hong Kong: study protocol for a randomized controlled trial. Trials. 2018;19(1):376. doi: 10.1186/s13063-018-2706-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Chen H, Wang C, Zhou M, Yan CP, Lo YL, Lok LW, et al. Electroacupuncture for post-stroke overactive bladder: a multi-centre pilot randomized controlled trial. Acupunct Med. 2021;39(3):175–183. doi: 10.1177/0964528420925488. [DOI] [PubMed] [Google Scholar]
  • 25.Liu Z, Liu Y, Xu H, He L, Chen Y, Fu L, et al. Effect of electroacupuncture on urinary leakage among women with stress urinary incontinence. JAMA. 2017;317(24):2493. doi: 10.1001/jama.2017.7220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Lee H, Yun Y, Choi J, Hong J, Lee I, Park S, et al. Effectiveness and safety of moxibustion for alleviating symptoms of overactive bladder. Medicine (Baltimore) 2018;97(34):e12016. doi: 10.1097/MD.0000000000012016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Park H, Lee H, Shin B, Liu J, Shang Q, Yamashita H, et al. Traditional medicine in China, Korea, and Japan: a brief introduction and comparison. Evid Based Complement Altern Med. 2012;2012:1–9. doi: 10.1155/2012/429103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Zhu Z, Zhuo Y, Jin H, Wu B, Li Z. Chinese medicine therapies for neurogenic bladder after spinal cord injury. Medicine (Baltimore) 2021;100(37):e27215. doi: 10.1097/MD.0000000000027215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Bauer BA, Tilburt JC, Sood A, Li GX, Wang SH. Complementary and alternative medicine therapies for chronic pain. Chin J Integr Med. 2016;22(6):403–411. doi: 10.1007/s11655-016-2258-y. [DOI] [PubMed] [Google Scholar]
  • 30.Xiao DD, Lv JW, Xie X, Jin XW, Lu MJ, Shao Y. The combination of herbal medicine weng-li-tong with tolterodine may be better than tolterodine alone in the treatment of overactive bladder in women: a randomized placebo-controlled prospective trial. Bmc Urol. 2016;16(1):49. doi: 10.1186/s12894-016-0167-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Karaaslan Y, Toprak Celenay S, Kucukdurmaz F. Comparison of pelvic floor muscle training with connective tissue massage to pelvic floor muscle training alone in women with overactive bladder: a randomized controlled study. J Manip Physiol Ther. 2021;44(4):295–306. doi: 10.1016/j.jmpt.2021.02.001. [DOI] [PubMed] [Google Scholar]
  • 32.Weiss JM. Pelvic floor myofascial trigger points: manual therapy for interstitial cystitis and the urgency-frequency syndrome. J Urol. 2001;166(6):2226–2231. doi: 10.1016/s0022-5347(05)65539-5. [DOI] [PubMed] [Google Scholar]
  • 33.Bartley J, Gilleran J, Peters K. Neuromodulation for overactive bladder. Nat Rev Urol. 2013;10(9):513–521. doi: 10.1038/nrurol.2013.143. [DOI] [PubMed] [Google Scholar]
  • 34.Yamaguchi O. Antimuscarinics and overactive bladder: other mechanism of action. Neurourol Urodyn. 2010;29(1):112–115. doi: 10.1002/nau.20796. [DOI] [PubMed] [Google Scholar]
  • 35.Matsumoto Y, Miyazato M, Yokoyama H, Kita M, Hirao Y, Chancellor MB, et al. Role of m2 and m3 muscarinic acetylcholine receptor subtypes in activation of bladder afferent pathways in spinal cord injured rats. Urology. 2012;79(5):1115–1184. doi: 10.1016/j.urology.2012.01.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Jensen RT, Battey JF, Spindel ER, Benya RV. International union of pharmacology. Lxviii. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states. Pharmacol Rev. 2008;60(1):1–42. doi: 10.1124/pr.107.07108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Chess-Williams R, Chapple CR, Yamanishi T, Yasuda K, Sellers DJ. The minor population of m3-receptors mediate contraction of human detrusor muscle in vitro. J Auton Pharmacol. 2001;21(5–6):243–248. doi: 10.1046/j.1365-2680.2001.00231.x. [DOI] [PubMed] [Google Scholar]
  • 38.Wang L, Fu YB, Liu Y, Yang NN, Ma SM, Wang XR, et al. Moxibustion attenuates neurogenic detrusor overactivity in spinal cord injury rats by inhibiting m2/atp/p2x3 pathway. Brain Res. 2022;1788:147926. doi: 10.1016/j.brainres.2022.147926. [DOI] [PubMed] [Google Scholar]
  • 39.Gholamnezhad Z, Ghorani V, Saadat S, Shakeri F, Boskabady MH. The effects of medicinal plants on muscarinic receptors in various types of smooth muscle. Phytother Res. 2018;32(12):2340–2363. doi: 10.1002/ptr.6179. [DOI] [PubMed] [Google Scholar]
  • 40.O'Reilly BA, Kosaka AH, Knight GF, Chang TK, Ford AP, Rymer JM, et al. P2x receptors and their role in female idiopathic detrusor instability. J Urol. 2002;167(1):157–164. doi: 10.1016/S0022-5347(05)65403-1. [DOI] [PubMed] [Google Scholar]
  • 41.Sun Y, Chai TC. Role of purinergic signaling in voiding dysfunction. Curr Bladder Dysfunct Rep. 2010;5(4):219–224. doi: 10.1007/s11884-010-0063-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Burnstock G. Therapeutic potential of purinergic signalling for diseases of the urinary tract. Bju Int. 2011;107(2):192–204. doi: 10.1111/j.1464-410X.2010.09926.x. [DOI] [PubMed] [Google Scholar]
  • 43.Takezawa K, Kondo M, Kiuchi H, Ueda N, Soda T, Fukuhara S, et al. Authentic role of atp signaling in micturition reflex. Sci Rep. 2016 doi: 10.1038/srep19585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Zhang S, Lv JW, Yang P, Yu Q, Pang J, Wang Z, et al. Loss of dicer exacerbates cyclophosphamide-induced bladder overactivity by enhancing purinergic signaling. Am J Pathol. 2012;181(3):937–946. doi: 10.1016/j.ajpath.2012.05.035. [DOI] [PubMed] [Google Scholar]
  • 45.Feng Q, Zhang A, Xing M, Wang X, Ming S, Chen Y. Electroacupuncture alleviates bladder overactivity via inhabiting bladder p2x3 receptor. Evid Based Complement Alternat Med. 2020;2020:1–12. doi: 10.1155/2020/4080891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Wang J, Lian DW, Yang XF, Xu YF, Chen FJ, Lin WJ, et al. Suo quan wan protects mouse from early diabetic bladder dysfunction by mediating motor protein myosin va and transporter protein slc17a9. Front Pharmacol. 2019;10:552. doi: 10.3389/fphar.2019.00552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Lee WC, Wu CC, Chuang YC, Tain YL, Chiang PH. Ba-wei-die-huang-wan (hachimi-jio-gan) can ameliorate cyclophosphamide-induced ongoing bladder overactivity and acidic adenosine triphosphate solution-induced hyperactivity on rats prestimulated bladder. J Ethnopharmacol. 2016;184:1–9. doi: 10.1016/j.jep.2015.12.026. [DOI] [PubMed] [Google Scholar]
  • 48.Andersson KE, Wein AJ. Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence. Pharmacol Rev. 2004;56(4):581–631. doi: 10.1124/pr.56.4.4. [DOI] [PubMed] [Google Scholar]
  • 49.Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327(6122):524–526. doi: 10.1038/327524a0. [DOI] [PubMed] [Google Scholar]
  • 50.Monica FZ, Antunes E. Stimulators and activators of soluble guanylate cyclase for urogenital disorders. Nat Rev Urol. 2018;15(1):42–54. doi: 10.1038/nrurol.2017.181. [DOI] [PubMed] [Google Scholar]
  • 51.Ma SX, Lee PC, Jiang I, Ma E, Hu JS, Li XY. Influence of age, gender, and race on nitric oxide release over acupuncture points-meridians. Sci Rep. 2015;5:17547. doi: 10.1038/srep17547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Hui B, Rong PJ, Li L, Gao XY, He W. Effects of different acupuncture stimulations on no content in acupoint areas. J Tradit Chin Med. 2010;30(1):25–29. doi: 10.1016/s0254-6272(10)60008-8. [DOI] [PubMed] [Google Scholar]
  • 53.Bae S, Lee KW, Jeong HC, Park BH, Bae WJ, Han CH, et al. Effects of a combination of herbal extracts (modified ojayeonjonghwan (wuzi yanzong wan)) on partial urethral obstruction-induced detrusor overactivity in rats: impact on the nitric oxide pathway and oxidative stress. Bmc Complement Altern Med. 2019;19(1):64. doi: 10.1186/s12906-019-2467-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Kim HY, Lee YJ, Han BH, Yoon JJ, Ahn YM, Hong MH, et al. Mantidis ootheca induces vascular relaxation through pi3k/akt-mediated nitric oxide-cyclic gmp-protein kinase g signaling in endothelial cells. J Physiol Pharmacol. 2017;68(2):215–221. [PubMed] [Google Scholar]
  • 55.Yamaguchi O. Beta3-adrenoceptors in human detrusor muscle. Urology. 2002;59(5 Suppl 1):25–29. doi: 10.1016/s0090-4295(01)01635-1. [DOI] [PubMed] [Google Scholar]
  • 56.Truss MC, Uckert S, Stief CG, Kuczyk M, Schulz-Knappe P, Forssmann WG, et al. Effects of various phosphodiesterase-inhibitors, forskolin, and sodium nitroprusside on porcine detrusor smooth muscle tonic responses to muscarinergic stimulation and cyclic nucleotide levels in vitro. Neurourol Urodyn. 1996;15(1):59–70. doi: 10.1002/(SICI)1520-6777(1996)15:1<59::AID-NAU6>3.0.CO;2-E. [DOI] [PubMed] [Google Scholar]
  • 57.Hall IP. Second messengers, ion channels and pharmacology of airway smooth muscle. Eur Respir J. 2000;15(6):1120–1127. doi: 10.1034/j.1399-3003.2000.01523.x. [DOI] [PubMed] [Google Scholar]
  • 58.Wallis RM, Napier CM. Muscarinic antagonists in development for disorders of smooth muscle function. Life Sci. 1999;64(6–7):395–401. doi: 10.1016/s0024-3205(98)00585-2. [DOI] [PubMed] [Google Scholar]
  • 59.Andersson KE. Neurotransmitters and neuroreceptors in the lower urinary tract. Curr Opin Obstet Gynecol. 1996;8(5):361–365. doi: 10.1097/00001703-199610000-00009. [DOI] [PubMed] [Google Scholar]
  • 60.Xu YF, Liang ZJ, Kuang ZJ, Chen JJ, Wu J, Lu XE, et al. Effect of suo quan wan on the bladder function of aging rats based on the beta-adrenoceptor. Exp Ther Med. 2017;13(6):3424–3432. doi: 10.3892/etm.2017.4394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Peyronnet B, Mironska E, Chapple C, Cardozo L, Oelke M, Dmochowski R, et al. A comprehensive review of overactive bladder pathophysiology: on the way to tailored treatment. Eur Urol. 2019;75(6):988–1000. doi: 10.1016/j.eururo.2019.02.038. [DOI] [PubMed] [Google Scholar]
  • 62.Parajuli SP, Zheng Y, Levin R, Wang Y. Big-conductance Ca2+-activated K+ channels in physiological and pathophysiological urinary bladder smooth muscle cells. Channels (Austin) 2016;10(5):355–364. doi: 10.1080/19336950.2016.1180488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Malysz J, Petkov GV. Urinary bladder smooth muscle ion channels: expression, function, and regulation in health and disease. Am J Physiol Renal Physiol. 2020;319(2):F257–F283. doi: 10.1152/ajprenal.00048.2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Hausmann ON. Post-traumatic inflammation following spinal cord injury. Spinal Cord. 2003;41(7):369–378. doi: 10.1038/sj.sc.3101483. [DOI] [PubMed] [Google Scholar]
  • 65.Miao L, Yun X, Yang X, Jia S, Jiao C, Shao R, et al. An inhibitory effect of berberine from herbal coptis chinensis franch on rat detrusor contraction in benign prostatic hyperplasia associated with lower urinary tract symptoms. J Ethnopharmacol. 2021;268:113666. doi: 10.1016/j.jep.2020.113666. [DOI] [PubMed] [Google Scholar]
  • 66.Jiang HM, Fu DW, Zang LE, Si SB, Song B. Effects of rhynchophylline on relaxation and contraction of the bladder detrusor in rats. Eur Rev Med Pharmacol Sci. 2013;17(16):2190–2197. [PubMed] [Google Scholar]
  • 67.Petkov GV. Role of potassium ion channels in detrusor smooth muscle function and dysfunction. Nat Rev Urol. 2011;9(1):30–40. doi: 10.1038/nrurol.2011.194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Saito M, Ohmasa F, Tsounapi P, Inoue S, Dimitriadis F, Kinoshita Y, et al. Nicorandil ameliorates hypertension-related bladder dysfunction in the rat. Neurourol Urodyn. 2012;31(5):695–701. doi: 10.1002/nau.21213. [DOI] [PubMed] [Google Scholar]
  • 69.Andersson KE, Andersson PO, Fovaeus M, Hedlund H, Malmgren A, Sjogren C. Effects of pinacidil on bladder muscle. Drugs. 1988;36(Suppl 7):41–49. doi: 10.2165/00003495-198800367-00007. [DOI] [PubMed] [Google Scholar]
  • 70.Sun J, Shen W, An W, Li Q, Qiu S, Jiang S. A chinese medicine formula “xian-jia-tang” for treating bladder outlet obstruction by improving urodynamics and inhibiting oxidative stress through potassium channels. Evid Based Complement Alternat Med. 2017;2017:1–8. doi: 10.1155/2017/8147258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Li S, Huang J, Guo Y, Wang J, Lu S, Wang B, et al. Pac1 receptor mediates electroacupuncture-induced neuro and immune protection during cisplatin chemotherapy. Front Immunol. 2021;12:714244. doi: 10.3389/fimmu.2021.714244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Hernandez M, Barahona MV, Recio P, Benedito S, Martinez AC, Rivera L, et al. Neuronal and smooth muscle receptors involved in the pacap- and vip-induced relaxations of the pig urinary bladder neck. Br J Pharmacol. 2006;149(1):100–109. doi: 10.1038/sj.bjp.0706832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Gillespie JI, Markerink-Van IM, de Vente J. Sensory collaterals, intramural ganglia and motor nerves in the guinea-pig bladder: evidence for intramural neural circuits. Cell Tissue Res. 2006;325(1):33–45. doi: 10.1007/s00441-006-0166-8. [DOI] [PubMed] [Google Scholar]
  • 74.Everaerts W, Gevaert T, Nilius B, De Ridder D. On the origin of bladder sensing: tr(i)ps in urology. Neurourol Urodyn. 2008;27(4):264–273. doi: 10.1002/nau.20511. [DOI] [PubMed] [Google Scholar]
  • 75.Grundy L, Daly DM, Chapple C, Grundy D, Chess-Williams R. Trpv1 enhances the afferent response to p2x receptor activation in the mouse urinary bladder. Sci Rep. 2018;8(1):197. doi: 10.1038/s41598-017-18136-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Cruz F, Dinis P. Resiniferatoxin and botulinum toxin type a for treatment of lower urinary tract symptoms. Neurourol Urodyn. 2007;26(6 Suppl):920–927. doi: 10.1002/nau.20479. [DOI] [PubMed] [Google Scholar]
  • 77.Macdonald R, Monga M, Fink HA, Wilt TJ. Neurotoxin treatments for urinary incontinence in subjects with spinal cord injury or multiple sclerosis: a systematic review of effectiveness and adverse effects. J Spinal Cord Med. 2008;31(2):157–165. doi: 10.1080/10790268.2008.11760706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Andersson KE, Chapple CR, Cardozo L, Cruz F, Hashim H, Michel MC, et al. Pharmacological treatment of overactive bladder: report from the international consultation on incontinence. Curr Opin Urol. 2009;19(4):380–394. doi: 10.1097/MOU.0b013e32832ce8a4. [DOI] [PubMed] [Google Scholar]
  • 79.Ning G, Hewei Q, Yanjie L, Li N, Yuqing N, Xuemei S, et al. Mechanism of electroacupuncture for neurogenic bladder in suprsacral spinal cord injury rats through mechanism of electroacupuncture for neurogenic bladder in suprsacral spinal cord injury rats through trpv1 channel. J Pract Med. 2021;37(24):3126–3131. [Google Scholar]
  • 80.Lai H, Tan B, Liang Z, Yan Q, Lian Q, Wu Q, et al. Effect of the chinese traditional prescription suo quan wan on trpv1 expression in the bladder of rats with bladder outlet obstruction. Bmc Complement Altern Med. 2015;15:424. doi: 10.1186/s12906-015-0898-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Choi S, Seo H, Lee K, Shin DH, Wu MJ, Wu W, et al. Hyperpolarization-activated cyclic nucleotide-gated channels working as pacemaker channels in colonic interstitial cells of cajal. J Cell Mol Med. 2022;26(2):364–374. doi: 10.1111/jcmm.17087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Lu JY, Ying XW, Chen XL, Tu WZ, Li SS, Jiang SH. Effects of electroacupuncture at different acupoints on the histomorphology of neurogenic bladder and the expression of hyperpolarization-activated cyclic nucleotide-gated channels in interstitial cells of cajal in a rat model of suprasacral spinal cord injury. Ann Palliat Med. 2020;9(6):3830-8. doi: 10.21037/apm-20-1827. [DOI] [PubMed] [Google Scholar]
  • 83.Feng Q, Hou Y, Hou W, Lin Z, Tang K, Chen Y. The effects of acupuncture on bladder interstitial cells of cajal excitability in rats with overactive bladder. Evid Based Complement Altern Med. 2013;2013:1–10. doi: 10.1155/2013/261217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Ashcroft FM. From molecule to malady. Nature. 2006;440(7083):440–447. doi: 10.1038/nature04707. [DOI] [PubMed] [Google Scholar]
  • 85.Takahashi R, Yoshizawa T, Yunoki T, Tyagi P, Naito S, de Groat WC, et al. Hyperexcitability of bladder afferent neurons associated with reduction of kv1.4 α-subunit in rats with spinal cord injury. J Urol. 2013;190(6):2296–2304. doi: 10.1016/j.juro.2013.07.058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Sengupta JN, Gebhart GF. Mechanosensitive properties of pelvic nerve afferent fibers innervating the urinary bladder of the rat. J Neurophysiol. 1994;72(5):2420–2430. doi: 10.1152/jn.1994.72.5.2420. [DOI] [PubMed] [Google Scholar]
  • 87.Rahnama'I MS, Biallosterski BT, Van Kerrebroeck PE, van Koeveringe GA, Gillespie JI, de Wachter SG. Distribution and sub-types of afferent fibre in the mouse urinary bladder. J Chem Neuroanat. 2017;79:1–11. doi: 10.1016/j.jchemneu.2016.10.003. [DOI] [PubMed] [Google Scholar]
  • 88.Shea VK, Cai R, Crepps B, Mason JL, Perl ER. Sensory fibers of the pelvic nerve innervating the rat's urinary bladder. J Neurophysiol. 2000;84(4):1924–1933. doi: 10.1152/jn.2000.84.4.1924. [DOI] [PubMed] [Google Scholar]
  • 89.de Groat WC, Griffiths D, Yoshimura N. Neural control of the lower urinary tract. Compr Physiol. 2015;5(1):327–396. doi: 10.1002/cphy.c130056. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Juszczak K, Ziomber A, Wyczolkowski M, Thor PJ. Urodynamic effects of the bladder c-fiber afferent activity modulation in chronic model of overactive bladder in rats. J Physiol Pharmacol. 2009;60(4):85–91. [PubMed] [Google Scholar]
  • 91.de Groat WC, Yoshimura N. Mechanisms underlying the recovery of lower urinary tract function following spinal cord injury. Prog Brain Res. 2006;152:59–84. doi: 10.1016/S0079-6123(05)52005-3. [DOI] [PubMed] [Google Scholar]
  • 92.de Groat WC, Kawatani M, Hisamitsu T, Cheng CL, Ma CP, Thor K, et al. Mechanisms underlying the recovery of urinary bladder function following spinal cord injury. J Auton Nerv Syst. 1990;30(Suppl):S71–S77. doi: 10.1016/0165-1838(90)90105-r. [DOI] [PubMed] [Google Scholar]
  • 93.Yang L, Wang Y, Mo Q, Liu Z. A comparative study of electroacupuncture at zhongliao (bl33) and other acupoints for overactive bladder symptoms. Front Med. 2017;11(1):129–136. doi: 10.1007/s11684-016-0491-6. [DOI] [PubMed] [Google Scholar]
  • 94.Noblett K, Siegel S, Mangel J, Griebling TL, Sutherland SE, Bird ET, et al. Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladder. Neurourol Urodyn. 2016;35(2):246–251. doi: 10.1002/nau.22707. [DOI] [PubMed] [Google Scholar]
  • 95.Wood LN, Anger JT. Urinary incontinence in women. BMJ. 2014;349:g4531. doi: 10.1136/bmj.g4531. [DOI] [PubMed] [Google Scholar]
  • 96.Yoshimura N, Seki S, Chancellor MB, de Groat WC, Ueda T. Targeting afferent hyperexcitability for therapy of the painful bladder syndrome. Urology. 2002;59(5 Suppl 1):61–67. doi: 10.1016/s0090-4295(01)01639-9. [DOI] [PubMed] [Google Scholar]
  • 97.Nishijima S, Sugaya K, Miyazato M, Ogawa Y. Effect of gosha-jinki-gan, a blended herbal medicine, on bladder activity in rats. J Urol. 2007;177(2):762–765. doi: 10.1016/j.juro.2006.09.077. [DOI] [PubMed] [Google Scholar]
  • 98.Maggi CA. The mammalian tachykinin receptors. Gen Pharmacol. 1995;26(5):911–944. doi: 10.1016/0306-3623(94)00292-u. [DOI] [PubMed] [Google Scholar]
  • 99.Chien CT, Yu HJ, Lin TB, Lai MK, Hsu SM. Substance p via nk1 receptor facilitates hyperactive bladder afferent signaling via action of ros. Am J Physiol Renal Physiol. 2003;284(4):F840–F851. doi: 10.1152/ajprenal.00187.2002. [DOI] [PubMed] [Google Scholar]
  • 100.Marchand JE, Sant GR, Kream RM. Increased expression of substance p receptor-encoding mrna in bladder biopsies from patients with interstitial cystitis. Br J Urol. 1998;81(2):224–228. doi: 10.1046/j.1464-410x.1998.00507.x. [DOI] [PubMed] [Google Scholar]
  • 101.Tsai WH, Wu CH, Cheng CH, Chien CT. Ba-wei-di-huang-wan through its active ingredient loganin counteracts substance p-enhanced nf-kappab/icam-1 signaling in rats with bladder hyperactivity. Neurourol Urodyn. 2016;35(7):771–779. doi: 10.1002/nau.22816. [DOI] [PubMed] [Google Scholar]
  • 102.Zare A, Jahanshahi A, Rahnama'I MS, Schipper S, van Koeveringe GA. The role of the periaqueductal gray matter in lower urinary tract function. Mol Neurobiol. 2019;56(2):920–934. doi: 10.1007/s12035-018-1131-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Ding YQ, Zheng HX, Gong LW, Lu Y, Zhao H, Qin BZ. Direct projections from the lumbosacral spinal cord to barrington's nucleus in the rat: a special reference to micturition reflex. J Comp Neurol. 1997;389(1):149–160. doi: 10.1002/(sici)1096-9861(19971208)389:1<149::aid-cne11>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  • 104.Kwon J, Lee EJ, Park HR, Cho HJ, Jang JA, Yang H, et al. Continuous administration of mirabegron has advantages in inhibition of central sensitization compared with short-term treatment cessation in a mouse model of overactive bladder. Neurourol Urodyn. 2022;41(6):1355–1363. doi: 10.1002/nau.24956. [DOI] [PubMed] [Google Scholar]
  • 105.Reynolds WS, Dmochowski R, Wein A, Bruehl S. Does central sensitization help explain idiopathic overactive bladder? Nat Rev Urol. 2016;13(8):481–491. doi: 10.1038/nrurol.2016.95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106.Baron R, Hans G, Dickenson AH. Peripheral input and its importance for central sensitization. Ann Neurol. 2013;74(5):630–636. doi: 10.1002/ana.24017. [DOI] [PubMed] [Google Scholar]
  • 107.Wang H, Tanaka Y, Kawauchi A, Miki T, Kayama Y, Koyama Y. Acupuncture of the sacral vertebrae suppresses bladder activity and bladder activity-related neurons in the brainstem micturition center. Neurosci Res. 2012;72(1):43–49. doi: 10.1016/j.neures.2011.09.007. [DOI] [PubMed] [Google Scholar]
  • 108.Hou S, Rabchevsky AG. Autonomic consequences of spinal cord injury. Compr Physiol. 2014;4(4):1419–1453. doi: 10.1002/cphy.c130045. [DOI] [PubMed] [Google Scholar]
  • 109.Xu M, Zhang H, Liu J, Yin X, Zhang J, Huang G, et al. Effect of electroacupuncture on expression of caspase-9, cytochrome c and apoptotic protease activating factor effect of electroacupuncture on expression of caspase-9, cytochrome c and apoptotic protease activating factor 1 in spinal tissue in rats with neurogenic bladder after complete spinal cord injury. Chin J Rehabil Theory Pract. 2017;23(06):628–633. [Google Scholar]
  • 110.Kumar V, Templeman L, Chapple CR, Chess-Williams R. Recent developments in the management of detrusor overactivity. Curr Opin Urol. 2003;13(4):285–291. doi: 10.1097/00042307-200307000-00004. [DOI] [PubMed] [Google Scholar]
  • 111.Ming X, Xiaomeng L, Kun A, Shifeng D, Yuchen Z, Ke H, et al. Effects of electroacupuncture on bladder function and intramedullary ngf and nt-3 in effects of electroacupuncture on bladder function and intramedullary ngf and nt-3 in neurogenic bladder rats after sacral spinal cord injury. J Hunan Univ Chin Med. 2021;41(02):252–258. [Google Scholar]
  • 112.Kun A, Hong Z, Zhijing K, Yucheng Z, Jingxing L, Qiuying B. Effect of electroacupuncture on the expression of nerve growth factor and tyrosine kinase receptor a in spinal cord of rats with neurogenic bladder after suprasacral spinal cord injury. Chin J Rehabil Med. 2014;29(10):948–950. [Google Scholar]
  • 113.Deng YN, Zhou DA, Xu XM, Liu L, Nie XJ, Ma XD, et al. effect of electroacupuncture on urodynamics and expression of wnt-1, beta-catenin, and ngn1 in the spinal cord in rats with bladder detrusor hyperreflexia due to supersacral spinal cord transection. Zhen Ci Yan Jiu. 2019;44(10):722–728. doi: 10.13702/j.1000-0607.190129. [DOI] [PubMed] [Google Scholar]
  • 114.Xiaodong L, Yulin H, Jihong S, Li W, Lin Z, Jianhua Z. The change and meaning of nerve growth factor in bladder of hight-level-spinal cord injured rats. J Kunming Med Univ. 2009;30(10):37–41. doi: 10.3969/j.issn.1003-4706.2009.10.010. [DOI] [Google Scholar]
  • 115.Lamb K, Gebhart GF, Bielefeldt K. Increased nerve growth factor expression triggers bladder overactivity. J Pain. 2004;5(3):150–156. doi: 10.1016/j.jpain.2004.01.001. [DOI] [PubMed] [Google Scholar]
  • 116.Sheng W, Zhang H, Ruth KH. Could urinary nerve growth factor be a biomarker for overactive bladder? A meta-analysis. Neurourol Urodyn. 2017;36(7):1703–1710. doi: 10.1002/nau.23210. [DOI] [PubMed] [Google Scholar]
  • 117.Antunes-Lopes T, Cruz F. Urinary biomarkers in overactive bladder: revisiting the evidence in 2019. Eur Urol Focus. 2019;5(3):329–336. doi: 10.1016/j.euf.2019.06.006. [DOI] [PubMed] [Google Scholar]
  • 118.Hashim H, Abrams P. Is the bladder a reliable witness for predicting detrusor overactivity? J Urol. 2006;175(1):191–195. doi: 10.1016/S0022-5347(05)00067-4. [DOI] [PubMed] [Google Scholar]
  • 119.Schneider MP, Hughes FJ, Engmann AK, Purves JT, Kasper H, Tedaldi M, et al. A novel urodynamic model for lower urinary tract assessment in awake rats. Bju Int. 2015;115(Suppl 6):8–15. doi: 10.1111/bju.13039. [DOI] [PubMed] [Google Scholar]
  • 120.Schneider MP, Sartori AM, Tampe J, Moors S, Engmann AK, Ineichen BV, et al. Urodynamic measurements reflect physiological bladder function in rats. Neurourol Urodyn. 2018;37(4):1266–1271. doi: 10.1002/nau.23455. [DOI] [PubMed] [Google Scholar]
  • 121.Feng Z, Liu W, Jiang HX, Dai H, Gao C, Dong Z, et al. How does herbal medicine treat idiopathic membranous nephropathy? Front Pharmacol. 2020;11:994. doi: 10.3389/fphar.2020.00994. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The datasets generated during or analysed during the current study are available from the corresponding author on reasonable request.


Articles from International Urology and Nephrology are provided here courtesy of Springer

RESOURCES